Health Advances competitors

Greg Hambright is a President & CEO at Afognak Native Corporation and is based in Anchorage, Alaska. He has worked as Sr VIce President at Alutiiq LLC.

Remco specializes in helping life-sciences organizations develop global go-to-market and product lifecycle maximization strategies, addressing critical external stakeholder groups and leveraging internal functional expertise. He also serves as Putnam’s Boston Office Head. Since joining Putnam in 2000, Remco has served clients in the pharmaceutical, biotech and medical device industries on projects focused in both domestic and international markets. His therapeutic area experience includes Vaccines, Oncology, CNS, Immunology, Infectious Disease, and Women’s Health. Remco’s most recent area of focus has been assisting organizations in defining the potential value of new compounds, making informed portfolio prioritization decisions, and formulating clinical development and commercialization plans that maximize return on investment. Prior to joining Putnam, Remco developed international expansion strategies for small and mid-size companies in the Netherlands and UK. Remco grew up in the Netherlands and received his bachelors degree in International Management from the Fontys University, Eindhoven, and his Masters degree in International Marketing from the University of Strathclyde in Glasgow, Scotland.

Paul Price is a Chairman & Chief Executive Officer at Argyle Executive Forum and is based in New York City, New York. He has worked as CEO at CreativeDrive, Global President at RAPP, and CEO at CoCreativ. Paul attended Swinburne University of Technology between 1990 and 1994, Columbia Business School between 1995 and 1995, and Babson College between 2007 and 2008.